Premium
The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet‐ and megakaryocyte‐derived TIMPs in bone marrow fibrosis
Author(s) -
Murate Takashi,
Yamashita Kyoko,
Isogai Chiho,
Suzuki Hitoshi,
Ichihara Masatoshi,
Hatano Sonoko,
Nakahara Yosuke,
Kinoshita Tomohiro,
Nagasaka Tetsuro,
Yoshida Shonen,
Komatsu Norio,
Miura Yasusada,
Hotta Tomomitsu,
Fujimoto Noboru,
Saito Hidehiko,
Hayakawa Taro
Publication year - 1997
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.1997.3293146.x
Subject(s) - polycythaemia , platelet , thrombocytosis , megakaryocytopoiesis , megakaryocyte , myelofibrosis , medicine , bone marrow , endocrinology , thrombopoietin , haematopoiesis , immunology , biology , stem cell , genetics
We quantified tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 in serum and plasma in normal control subjects and patients with a low or high platelet count, using one‐step sandwich enzyme immunoassays. The serum levels of TIMP‐1 and TIMP‐2 were 101.1 ± 13.3 ng/ml, and 82.7 ± 26.3 ng/ml, respectively, in normal subjects. In patients with an elevated platelet count, such as in essential thrombocytosis, polycythaemia vera, and myelofibrosis, serum levels of TIMP‐1 and TIMP‐2 were 351.6 ± 200.9 ng/ml and 148.9 ± 84.0 ng/ml, respectively. Serum levels of TIMP‐1 and TIMP‐2 in patients with a low platelet count, such as in aplastic anaemia and idiopathic thrombocytopenic purpura, were 57.2 ± 25.8 ng/ml and 19.7 ± 7.68 ng/ml, respectively. The serum level of TIMP‐1 was significantly correlated with the platelet count in all subjects. The correlation between the serum level of TIMP‐2 and the platelet count was not as strong. The level of TIMP‐1 in platelet‐depleted plasma was not correlated with the platelet count. Immunohistochemical staining using monoclonal antibodies against TIMP‐1 and TIMP‐2 showed that megakaryocytes and platelets were positive for both TIMP‐1 and TIMP‐2, confirming that they are rich sources of TIMPs. TIMP‐1 and TIMP‐2 stimulated the proliferation of bone marrow fibroblasts, although their effect was less potent than that of TGF‐β and PDGF. Erythroleukaemia and megakaryoblastic cell lines showed the highest secretion of TIMP‐1 among the leukaemia cell lines examined. There was no lineage specificity for TIMP‐2 secretion. These results suggest that TIMPs released from megakaryocytes or from local platelet coagulation may be important in the development of bone marrow fibrosis.